TrialEuropean journal of nuclear medicine and molecular imaging2023

[89Zr]-immuno-PET prediction of response to rituximab treatment in patients with therapy refractory interstitial pneumonitis: a phase 2 trial.

H Adams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.